ARS Pharmaceuticals, Inc. (SPRY)
5.89
-0.14
(-2.32%)
USD |
NASDAQ |
Aug 28, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Market Cap : 585.69M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 585.69M |
| August 27, 2026 | 599.61M |
| August 26, 2026 | 599.61M |
| August 25, 2026 | 568.78M |
| August 24, 2026 | 531.99M |
| August 21, 2026 | 547.41M |
| August 20, 2026 | 547.41M |
| August 19, 2026 | 634.41M |
| August 18, 2026 | 626.46M |
| August 17, 2026 | 620.49M |
| August 14, 2026 | 561.82M |
| August 13, 2026 | 606.57M |
| August 12, 2026 | 601.60M |
| August 11, 2026 | 591.66M |
| August 10, 2026 | 586.86M |
| August 07, 2026 | 611.69M |
| August 06, 2026 | 551.12M |
| August 05, 2026 | 532.25M |
| August 04, 2026 | 528.28M |
| August 03, 2026 | 542.18M |
| July 31, 2026 | 509.41M |
| July 30, 2026 | 559.06M |
| July 29, 2026 | 578.92M |
| July 28, 2026 | 563.03M |
| July 27, 2026 | 571.97M |
| Date | Value |
|---|---|
| July 24, 2026 | 589.84M |
| July 23, 2026 | 595.80M |
| July 22, 2026 | 601.76M |
| July 21, 2026 | 631.55M |
| July 20, 2026 | 639.49M |
| July 17, 2026 | 695.10M |
| July 16, 2026 | 740.78M |
| July 15, 2026 | 749.72M |
| July 14, 2026 | 755.67M |
| July 13, 2026 | 768.58M |
| July 10, 2026 | 788.44M |
| July 09, 2026 | 782.48M |
| July 08, 2026 | 804.33M |
| July 07, 2026 | 813.27M |
| July 06, 2026 | 827.17M |
| July 02, 2026 | 850.01M |
| July 01, 2026 | 788.44M |
| June 30, 2026 | 795.39M |
| June 29, 2026 | 850.01M |
| June 26, 2026 | 848.02M |
| June 25, 2026 | 796.39M |
| June 24, 2026 | 1.047B |
| June 23, 2026 | 1.021B |
| June 22, 2026 | 991.02M |
| June 18, 2026 | 958.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Passage Bio, Inc. | 14.54M |
| Vertex Pharmaceuticals, Inc. | 137.24B |
| Capricor Therapeutics, Inc. | 557.27M |
| Kyntra Bio, Inc. | 32.47M |
| Zentalis Pharmaceuticals, Inc. | 272.34M |
Market Cap Related Metrics
| PS Ratio | 4.993 |
| PEG Ratio | -0.0079 |
| Price to Book Value | 46.81 |
| Price | 5.89 |
| Earnings Yield | -36.89% |
| PEGY Ratio | -0.0079 |